Clinomics (XKRX:352770) Ending Cash Position : ₩7,783 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clinomics Ending Cash Position?

Clinomics's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩7,783 Mil.

Clinomics's quarterly Ending Cash Position declined from Sep. 2023 (₩26,879 Mil) to Dec. 2023 (₩11,046 Mil) and declined from Dec. 2023 (₩11,046 Mil) to Mar. 2024 (₩7,783 Mil).

Clinomics's annual Ending Cash Position declined from Dec. 2021 (₩16,836 Mil) to Dec. 2022 (₩8,599 Mil) but then increased from Dec. 2022 (₩8,599 Mil) to Dec. 2023 (₩11,046 Mil).

Clinomics Ending Cash Position Historical Data

The historical data trend for Clinomics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinomics Ending Cash Position Chart

Clinomics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,571.99

12,832.51

16,835.75

8,598.61

11,046.15

Clinomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial													8,008.28	6,145.00	26,878.76	11,046.15	7,782.99

Clinomics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Clinomics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8598.61	+	2447.544
	=	11,046

Clinomics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11046.154	+	-3263.161
	=	7,783

Clinomics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Clinomics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinomics (XKRX:352770) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinomics Inc (XKRX:352770) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Unist-Gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919

Website

http://www.clinomics.com

Clinomics Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology.

Clinomics (XKRX:352770) Headlines

No Headlines